Roche is the world’s largest biotech company and a global pioneer in diagnostics. Headquartered in Basel, Switzerland it has its home at the heart of Europe and today employs over 40,000 people, has significant R&D and manufacturing capabilities, and maintains a strong commitment to ensuring new medicines and integrated solutions are available and accessible to patients in all European countries, as and when they need them.
Europe has long stood strong as a leader in healthcare. It is the home of great scientists, physicians and academic institutions, a leader in the provision of universal healthcare, and a base for many of the innovative industries that have driven advances in patient care and outcomes. It has valued the health of its citizens, and understood the importance of science and innovation to improving it. In recent years, we have seen the global healthcare innovation landscape evolve and while the EU has made considerable progress to ensure that fundamental rights of EU citizens are protected, its efforts to leverage the benefits of digitalization and EU-wide data exchange for health and healthcare trail those of the US and China.
It doesn’t have to be like this – Europe has what it will take to address this challenge and has already announced an important new commitment to a European Health Union. With a bold and optimistic Pharmaceutical Strategy that uses transformative advances in science, technology, and the delivery of healthcare, Europe can boost patient outcomes, foster greater system sustainability and further confirm its position as a destination for healthcare innovation and investment.
We believe in the future of Europe as a centre for healthcare innovation and world class patient outcomes. We are committed to doing all we can to help make it a reality. Read more here.